Cramer's lightning round: Buy Vistra

Source

In this article

Stock Chart Icon Stock chart icon
hide content
Fair Isaac's year-to-date stock performance.

Fair Isaac Corporation: "This is a company a lot of people feel will be hurt by AI. I like the company, but I'm not going to go there because I'm not going to get in the crosshairs anymore of these companies that might get hurt by AI. It's too painful."

Stock Chart Icon Stock chart icon
hide content
Clover Health Investments' year-to-date stock performance.

Clover Health Investments: "You could say that I was not bullish enough on it. I'm focused on how great United Health is, and how great CVS is, but yes as a spec, that one was right, but I like mine for the long haul."

Stock Chart Icon Stock chart icon
hide content
Vistra's year-to-date stock performance.

Vistra: "It went too high. It's come back down. I'm going to bless it. [Buy, buy, buy.] It is a falling knife. I know I would only put on like 25% of my position, but it's too low."

Stock Chart Icon Stock chart icon
hide content
Stryker's year-to-date stock performance.

Stryker: "I kept thinking that there would be consolidator and Stryker would do the consolidating...and it has not come true...I thought they would work out something, and they haven't."

Jim Cramer's Guide to Investing

Click here to read Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest smarter

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.